Scholars@Duke

Niacin: Risk benefits and role in treating dyslipidemias

Publication ,  Chapter
Guyton, JR; Campbell, KB; Lakey, WC
January 1, 2015
Published version (DOI)

Duke Scholars

John Richard Guyton
Author John Richard Guyton Medicine, Endocrinology, Metabolism, and Nutrition
Wanda Cook Lakey
Author Wanda Cook Lakey Medicine, Endocrinology, Metabolism, and Nutrition

DOI

10.1007/978-1-60761-424-1_26

Publication Date

January 1, 2015

Volume

1

Start / End Page

439 / 452
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guyton, J. R., Campbell, K. B., & Lakey, W. C. (2015). Niacin: Risk benefits and role in treating dyslipidemias (Vol. 1, pp. 439–452). https://doi.org/10.1007/978-1-60761-424-1_26
Guyton, J. R., K. B. Campbell, and W. C. Lakey. “Niacin: Risk benefits and role in treating dyslipidemias,” 1:439–52, 2015. https://doi.org/10.1007/978-1-60761-424-1_26.
Guyton JR, Campbell KB, Lakey WC. Niacin: Risk benefits and role in treating dyslipidemias. In 2015. p. 439–52.
Guyton, J. R., et al. Niacin: Risk benefits and role in treating dyslipidemias. Vol. 1, 2015, pp. 439–52. Scopus, doi:10.1007/978-1-60761-424-1_26.
Guyton JR, Campbell KB, Lakey WC. Niacin: Risk benefits and role in treating dyslipidemias. 2015. p. 439–452.

DOI

10.1007/978-1-60761-424-1_26

Publication Date

January 1, 2015

Volume

1

Start / End Page

439 / 452